TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2013

The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.

Rudolph M Navari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.